Dual-Mechanism Drop Wins FDA Approval

• February 2, 2026

The Evolution of Treatments for Emmetropic Presbyopia

Often, these patients are unhappy with this reality check of aging and do not want to wear reading glasses, which is why practitioners and industry are always looking for ways to help. The challenge is to develop therapies that correct presbyopia while maintaining the emmetrope’s clear distance vision.

• by Robert Ang, MD

• January 1, 2025

• 6 min

The Growth Potential of Refractive Surgery for Myopia

Capitalizing on the growth potential of refractive surgery hinges on embracing an array of procedures, challenging conventional mindsets and prioritizing patient-centered care.

• by Yuna Rapoport, MD, MPH

• January 1, 2025

• 10 min

Lenz Therapeutics Announces FDA Approval of Vizz for the Treatment of Presbyopia

Near vision improvements were demonstrated within 30 minutes and lasted up to 10 hours in clinical trials.

• July 8, 2025

• 2 min